Article 05 Jul 2024 FDA Approves Three Biosimilars – Ahzantive® (Aflibercept-mrbb), Nypozi™ (Filgrastim-txid), And Pyzchiva® (Ustekinumab-ttwe) United States Healthcare
Article 05 Jul 2024 Maryland Requires Baby Food Manufacturers To Test For Toxic Heavy Metals United States Healthcare
Article 04 Jul 2024 AI Robocalls: Election Season Triggers Additional FCC Scrutiny United States Technology
Article 04 Jul 2024 District Of Columbia Establishes New Tax Incentives For Office Repositioning In Downtown United States Real Estate
Article 03 Jul 2024 PTAB Issues Final Written Decision Invalidating Regeneron's EYLEA® Patent (IPR2023-00442) United States IP
Article 02 Jul 2024 Supreme Court Overrules Chevron: Agency Deference In Flux United States Government
Article 02 Jul 2024 For U.S. Market Entry, Don't Overlook Abbreviated Applications To FDA For Drugs, Biologics, And Devices United States Healthcare
Article 02 Jul 2024 Supreme Court Strikes Down Bankruptcy Courts' Ability to Order Non-consensual Third-Party Releases United States Insolvency